{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:07:48Z","timestamp":1793138868727,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1038\/s41401-024-01303-x","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T16:02:04Z","timestamp":1716566524000},"page":"2134-2148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A new mechanism of thyroid hormone receptor \u03b2 agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles"],"prefix":"10.1038","volume":"45","author":[{"given":"Kai","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-pei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"1303_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347.","journal-title":"Hepatology"},{"key":"1303_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu X, Poulsen KL, Wu L, Liu S, Miyata T, Song Q, et al. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct Target Ther. 2022;7:287. https:\/\/doi.org\/10.1038\/s41392-022-01119-3.","journal-title":"Signal Transduct Target Ther"},{"key":"1303_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","volume":"15","author":"L Hodson","year":"2019","unstructured":"Hodson L, Gunn PJ. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. Nat Rev Endocrinol. 2019;15:689\u2013700.","journal-title":"Nat Rev Endocrinol"},{"key":"1303_CR4","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537\u201364.","journal-title":"Cell"},{"key":"1303_CR5","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/ijerph16173011","volume":"16","author":"L Abenavoli","year":"2019","unstructured":"Abenavoli L, Boccuto L, Federico A, Dallio M, Loguercio C, Di Renzo L, et al. Diet and non-alcoholic fatty liver disease: the mediterranean way. Int J Environ Res Public Health. 2019;16:3011. https:\/\/doi.org\/10.3390\/ijerph16173011.","journal-title":"Int J Environ Res Public Health"},{"key":"1303_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22:429\u201343.","journal-title":"Nat Rev Immunol"},{"key":"1303_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94:355\u201382.","journal-title":"Physiol Rev"},{"key":"1303_CR8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/hep.31296","volume":"72","author":"MJ Ritter","year":"2020","unstructured":"Ritter MJ, Amano I, Hollenberg AN. Thyroid hormone signaling and the liver. Hepatology. 2020;72:742\u201352.","journal-title":"Hepatology"},{"key":"1303_CR9","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1021\/jm4019299","volume":"57","author":"MJ Kelly","year":"2014","unstructured":"Kelly MJ, Pietranico-Cole S, Larigan JD, Haynes NE, Reynolds CH, Scott N, et al. Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a highly selective thyroid hormone receptor \u03b2 agonist in clinical trials for the treatment of dyslipidemia. J Med Chem. 2014;57:3912\u201323.","journal-title":"J Med Chem"},{"key":"1303_CR10","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, Taub R, Neff GW, Lucas KJ, Labriola D, Moussa SE, et al. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2023;29:2919\u201328.","journal-title":"Nat Med"},{"key":"1303_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrendo.2018.10","volume":"14","author":"RA Sinha","year":"2018","unstructured":"Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol. 2018;14:259\u201369.","journal-title":"Nat Rev Endocrinol"},{"key":"1303_CR12","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/15548627.2015.1061849","volume":"11","author":"RA Sinha","year":"2015","unstructured":"Sinha RA, Singh BK, Zhou J, Wu Y, Farah BL, Ohba K, et al. Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling. Autophagy. 2015;11:1341\u201357.","journal-title":"Autophagy"},{"key":"1303_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/thy.2018.0664","volume":"29","author":"RA Sinha","year":"2019","unstructured":"Sinha RA, Bruinstroop E, Singh BK, Yen PM. Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists. Thyroid. 2019;29:1173\u201391.","journal-title":"Thyroid"},{"key":"1303_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/501739","volume":"2009","author":"T Li","year":"2009","unstructured":"Li T, Chiang JY. Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res. 2009;2009:501739. https:\/\/doi.org\/10.1155\/2009\/501739.","journal-title":"PPAR Res"},{"key":"1303_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang JY. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191\u2013212.","journal-title":"Compr Physiol"},{"key":"1303_CR16","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1172\/JCI0216309","volume":"110","author":"J Li-Hawkins","year":"2002","unstructured":"Li-Hawkins J, G\u00e5fvels M, Olin M, Lund EG, Andersson U, Schuster G, et al. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest. 2002;110:1191\u2013200.","journal-title":"J Clin Invest"},{"key":"1303_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3727\/105221618X15156018385515","volume":"18","author":"JYL Chiang","year":"2018","unstructured":"Chiang JYL, Ferrell JM. Bile acid metabolism in liver pathobiology. Gene Expr. 2018;18:71\u201387.","journal-title":"Gene Expr"},{"key":"1303_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","volume":"12","author":"W Jia","year":"2021","unstructured":"Jia W, Wei M, Rajani C, Zheng X. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 2021;12:411\u201325.","journal-title":"Protein Cell"},{"key":"1303_CR19","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1210\/en.2011-2081","volume":"153","author":"JZ Lin","year":"2012","unstructured":"Lin JZ, Martagon AJ, Hsueh WA, Baxter JD, Gustafsson JA, Webb P, et al. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. Endocrinology. 2012;153:6136\u201344.","journal-title":"Endocrinology"},{"key":"1303_CR20","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1194\/jlr.M051664","volume":"55","author":"Y Bonde","year":"2014","unstructured":"Bonde Y, Breuer O, Lutjohann D, Sjoberg S, Angelin B, Rudling M. Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans. J Lipid Res. 2014;55:2408\u201315.","journal-title":"J Lipid Res"},{"key":"1303_CR21","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1073\/pnas.0504379102","volume":"102","author":"L Johansson","year":"2005","unstructured":"Johansson L, Rudling M, Scanlan TS, Lund\u00e5sen T, Webb P, Baxter J, et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci USA. 2005;102:10297\u2013302.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1303_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1073\/pnas.0705286104","volume":"105","author":"A Berkenstam","year":"2008","unstructured":"Berkenstam A, Kristensen J, Mellstr\u00f6m K, Carlsson B, Malm J, Rehnmark S, et al. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci USA. 2008;105:663\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1303_CR23","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1172\/JCI73419","volume":"124","author":"I Astapova","year":"2014","unstructured":"Astapova I, Ramadoss P, Costa-e-Sousa RH, Ye F, Holtz KA, Li Y, et al. Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRbeta1-governed pathway. J Clin Invest. 2014;124:1976\u201386.","journal-title":"J Clin Invest"},{"key":"1303_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34258-w","volume":"13","author":"Y Yan","year":"2022","unstructured":"Yan Y, Niu Z, Sun C, Li P, Shen S, Liu S, et al. Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism. Nat Commun. 2022;13:6408. https:\/\/doi.org\/10.1038\/s41467-022-34258-w.","journal-title":"Nat Commun"},{"key":"1303_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53:810\u201320.","journal-title":"Hepatology"},{"key":"1303_CR26","doi-asserted-by":"publisher","first-page":"e115922","DOI":"10.1371\/journal.pone.0115922","volume":"9","author":"W Liang","year":"2014","unstructured":"Liang W, Menke AL, Driessen A, Koek GH, Lindeman JH, Stoop R, et al. Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PLoS One. 2014;9:e115922. https:\/\/doi.org\/10.1371\/journal.pone.0115922.","journal-title":"PLoS One"},{"key":"1303_CR27","doi-asserted-by":"publisher","first-page":"9662","DOI":"10.1021\/acs.analchem.5b01556","volume":"87","author":"MH Sarafian","year":"2015","unstructured":"Sarafian MH, Lewis MR, Pechlivanis A, Ralphs S, Mcphail MJW, Patel VC, et al. Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry. Anal Chem. 2015;87:9662\u201370.","journal-title":"Anal Chem"},{"key":"1303_CR28","doi-asserted-by":"publisher","first-page":"12360","DOI":"10.1021\/acs.analchem.7b03404","volume":"89","author":"T Cajka","year":"2017","unstructured":"Cajka T, Smilowitz JT, Fiehn O. Validating quantitative untargeted lipidomics across nine liquid chromatographyhigh-resolution mass spectrometry platforms. Anal Chem. 2017;89:12360\u20138.","journal-title":"Anal Chem"},{"key":"1303_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"HR Jin","year":"2023","unstructured":"Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16:103. https:\/\/doi.org\/10.1186\/s13045-023-01498-2.","journal-title":"J Hematol Oncol"},{"key":"1303_CR30","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","volume":"33","author":"BL Clifford","year":"2021","unstructured":"Clifford BL, Sedgeman LR, Williams KJ, Morand P, Cheng A, Jarrett KE, et al. FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. Cell Metab. 2021;33:1671\u201384.e4.","journal-title":"Cell Metab"},{"key":"1303_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11692-017-9436-5","volume":"45","author":"M Malcicka","year":"2018","unstructured":"Malcicka M, Visser B, Ellers J. An evolutionary perspective on linoleic acid synthesis in animals. Evol Biol. 2018;45:15\u201326.","journal-title":"Evol Biol"},{"key":"1303_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","volume":"39","author":"JYL Chiang","year":"2019","unstructured":"Chiang JYL, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr. 2019;39:175\u2013200.","journal-title":"Annu Rev Nutr"},{"key":"1303_CR33","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"JY Chiang","year":"2009","unstructured":"Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955\u201366.","journal-title":"J Lipid Res"},{"key":"1303_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/03602532.2012.740048","volume":"45","author":"T Li","year":"2013","unstructured":"Li T, Chiang JY. Nuclear receptors in bile acid metabolism. Drug Metab Rev. 2013;45:145\u201355.","journal-title":"Drug Metab Rev"},{"key":"1303_CR35","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","volume":"50","author":"PA Dawson","year":"2009","unstructured":"Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009;50:2340\u201357.","journal-title":"J Lipid Res"},{"key":"1303_CR36","doi-asserted-by":"publisher","unstructured":"Zhong S, Ch\u00e8vre R, Casta\u00f1o Mayan D, Corlian\u00f2 M, Cochran BJ, Sem KP, et al. Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans. J Clin Invest. 2022;132. https:\/\/doi.org\/10.1172\/JCI152961.","DOI":"10.1172\/JCI152961"},{"key":"1303_CR37","doi-asserted-by":"publisher","first-page":"41690","DOI":"10.1074\/jbc.M105117200","volume":"276","author":"M Zhang","year":"2001","unstructured":"Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression. J Biol Chem. 2001;276:41690\u20139.","journal-title":"J Biol Chem"},{"key":"1303_CR38","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","volume":"4","author":"S Gallage","year":"2022","unstructured":"Gallage S, Avila JEB, Ramadori P, Focaccia E, Rahbari M, Ali A, et al. A researcher\u2019s guide to preclinical mouse NASH models. Nat Metab. 2022;4:1632\u201349.","journal-title":"Nat Metab"},{"key":"1303_CR39","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet"},{"key":"1303_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100104","volume":"62","author":"O Vvedenskaya","year":"2021","unstructured":"Vvedenskaya O, Rose TD, Knittelfelder O, Palladini A, Wodke JAH, Schuhmann K, et al. Nonalcoholic fatty liver disease stratification by liver lipidomics. J Lipid Res. 2021;62:100104. https:\/\/doi.org\/10.1016\/j.jlr.2021.100104.","journal-title":"J Lipid Res"},{"key":"1303_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1194\/jlr.M600413-JLR200","volume":"48","author":"R Bartz","year":"2007","unstructured":"Bartz R, Li WH, Venables B, Zehmer JK, Roth MR, Welti R, et al. Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic. J Lipid Res. 2007;48:837\u201347.","journal-title":"J Lipid Res"},{"key":"1303_CR42","doi-asserted-by":"publisher","first-page":"44507","DOI":"10.1074\/jbc.M207712200","volume":"277","author":"K Tauchi-Sato","year":"2002","unstructured":"Tauchi-Sato K, Ozeki S, Houjou T, Taguchi R, Fujimoto T. The surface of lipid droplets is a phospholipid monolayer with a unique Fatty Acid composition. J Biol Chem. 2002;277:44507\u201312.","journal-title":"J Biol Chem"},{"key":"1303_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s42255-022-00559-z","volume":"4","author":"A Perino","year":"2022","unstructured":"Perino A, Schoonjans K. Metabolic messengers: bile acids. Nat Metab. 2022;4:416\u201323.","journal-title":"Nat Metab"},{"key":"1303_CR44","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020;318:G554\u2013g73.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1303_CR45","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3389\/fphar.2018.01283","volume":"9","author":"N Pavlovic","year":"2018","unstructured":"Pavlovic N, Golocorbin-Kon S, Ethanic M, Stanimirov B, Al-Salami H, Stankov K, et al. Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Front Pharmacol. 2018;9:1283. https:\/\/doi.org\/10.3389\/fphar.2018.01283.","journal-title":"Front Pharm"},{"key":"1303_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100134","volume":"62","author":"R Li","year":"2021","unstructured":"Li R, Palmiotti A, de Vries HD, Hovingh MV, Koehorst M, Mulder NL, et al. Low production of 12alpha-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70(-\/-) mice by reducing fat absorption. J Lipid Res. 2021;62:100134. https:\/\/doi.org\/10.1016\/j.jlr.2021.100134.","journal-title":"J Lipid Res"},{"key":"1303_CR47","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.2337\/db14-0716","volume":"64","author":"A Kaur","year":"2015","unstructured":"Kaur A, Patankar JV, de Haan W, Ruddle P, Wijesekara N, Groen AK, et al. Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1. Diabetes. 2015;64:1168\u201379.","journal-title":"Diabetes"},{"key":"1303_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1089359","volume":"9","author":"H Bing","year":"2022","unstructured":"Bing H, Li YL. The role of bile acid metabolism in the occurrence and development of NAFLD. Front Mol Biosci. 2022;9:1089359. https:\/\/doi.org\/10.3389\/fmolb.2022.1089359.","journal-title":"Front Mol Biosci"},{"key":"1303_CR49","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","volume":"67","author":"N Jiao","year":"2018","unstructured":"Jiao N, Baker SS, Chapa-Rodriguez A, Liu W, Nugent CA, Tsompana M, et al. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2018;67:1881\u201391.","journal-title":"Gut"},{"key":"1303_CR50","doi-asserted-by":"publisher","first-page":"e0151829","DOI":"10.1371\/journal.pone.0151829","volume":"11","author":"M Mouzaki","year":"2016","unstructured":"Mouzaki M, Wang AY, Bandsma R, Comelli EM, Arendt BM, Zhang L, et al. Bile acids and dysbiosis in non-alcoholic fatty liver disease. PLoS One. 2016;11:e0151829. https:\/\/doi.org\/10.1371\/journal.pone.0151829.","journal-title":"PLoS One"},{"key":"1303_CR51","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/acs.jproteome.0c00852","volume":"20","author":"C Sang","year":"2021","unstructured":"Sang C, Wang X, Zhou K, Sun T, Bian H, Gao X, et al. Bile Acid Profiles Are distinct among patients with different etiologies of chronic liver disease. J Proteome Res. 2021;20:2340\u201351.","journal-title":"J Proteome Res"},{"key":"1303_CR52","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/hep.29359","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri P, Daita K, Joyce A, Mirshahi F, Santhekadur PK, Cazanave S, et al. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology. 2018;67:534\u201348.","journal-title":"Hepatology"},{"key":"1303_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20838-9","volume":"12","author":"W Iwasaki","year":"2022","unstructured":"Iwasaki W, Yoshida R, Liu H, Hori S, Otsubo Y, Tanaka Y, et al. The ratio of 12alpha to non-12-hydroxylated bile acids reflects hepatic triacylglycerol accumulation in high-fat diet-fed C57BL\/6J mice. Sci Rep. 2022;12:16707. https:\/\/doi.org\/10.1038\/s41598-022-20838-9.","journal-title":"Sci Rep"},{"key":"1303_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100255","volume":"3","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Ling L, Beuers U, DePaoli AM, Lieu HD, Harrison SA, et al. Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases. JHEP Rep. 2021;3:100255. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100255.","journal-title":"JHEP Rep"},{"key":"1303_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108412","volume":"83","author":"S Hori","year":"2020","unstructured":"Hori S, Abe T, Lee DG, Fukiya S, Yokota A, Aso N, et al. Association between 12alpha-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet. J Nutr Biochem. 2020;83:108412. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108412.","journal-title":"J Nutr Biochem"},{"key":"1303_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158811","volume":"1865","author":"JY Lee","year":"2020","unstructured":"Lee JY, Shimizu H, Hagio M, Fukiya S, Watanabe M, Tanaka Y, et al. 12\u03b1-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865:158811. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158811.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1303_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657\u201369.","journal-title":"Cell Metab"},{"key":"1303_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","volume":"4","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res. 2020;4:47\u201363.","journal-title":"Liver Res"},{"key":"1303_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/hep4.1129","volume":"2","author":"AC Donepudi","year":"2018","unstructured":"Donepudi AC, Ferrell JM, Boehme S, Choi HS, Chiang JYL. Deficiency of cholesterol 7alpha-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice. Hepatol Commun. 2018;2:99\u2013112.","journal-title":"Hepatol Commun"},{"key":"1303_CR60","doi-asserted-by":"publisher","unstructured":"Grevengoed TJ, Trammell SA, Svenningsen JS, Makarov MV, Nielsen TS, Jacobsen JCB, et al. An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides. J Clin Invest. 2021;131. https:\/\/doi.org\/10.1172\/JCI143861.","DOI":"10.1172\/JCI143861"},{"key":"1303_CR61","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1136\/gutjnl-2019-319693","volume":"69","author":"S Higuchi","year":"2020","unstructured":"Higuchi S, Ahmad TR, Argueta DA, Perez PA, Zhao C, Schwartz GJ, et al. Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice. Gut. 2020;69:1620\u20138.","journal-title":"Gut"},{"key":"1303_CR62","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.cmet.2016.01.001","volume":"23","author":"B Wang","year":"2016","unstructured":"Wang B, Rong X, Duerr MA, Hermanson DJ, Hedde PN, Wong JS, et al. Intestinal phospholipid remodeling is required for dietary-lipid uptake and survival on a high-fat diet. Cell Metab. 2016;23:492\u2013504.","journal-title":"Cell Metab"},{"key":"1303_CR63","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114742","volume":"14","author":"M Wit","year":"2022","unstructured":"Wit M, Trujillo-Viera J, Strohmeyer A, Klingenspor M, Hankir M, Sumara G. When fat meets the gut-focus on intestinal lipid handling in metabolic health and disease. EMBO Mol Med. 2022;14:e14742. https:\/\/doi.org\/10.15252\/emmm.202114742.","journal-title":"EMBO Mol Med"},{"key":"1303_CR64","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fendo.2018.00382","volume":"9","author":"MA Kowalik","year":"2018","unstructured":"Kowalik MA, Columbano A, Perra A. Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease. Front Endocrinol. 2018;9:382. https:\/\/doi.org\/10.3389\/fendo.2018.00382.","journal-title":"Front Endocrinol"},{"key":"1303_CR65","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1572-0241.1998.341_u.x","volume":"93","author":"R Goswami","year":"1998","unstructured":"Goswami R, Tandon RK, Dudha A, Kochupillai N. Prevalence and significance of steatorrhea in patients with active Graves\u2019 disease. Am J Gastroenterol. 1998;93:1122\u20135.","journal-title":"Am J Gastroenterol"},{"key":"1303_CR66","first-page":"195","volume":"89","author":"GC Misra","year":"1991","unstructured":"Misra GC, Bose SL, Samal AK. Malabsorption in thyroid dysfunctions. J Indian Med Assoc. 1991;89:195\u20137.","journal-title":"J Indian Med Assoc"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01303-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01303-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01303-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T08:08:25Z","timestamp":1727078905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01303-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01303-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}